Metsiou Despoina Nektaria, Kozaniti Foteini K, Deligianni Despina D
Laboratory of Biomechanics and Biomedical Engineering, Department of Mechanical Engineering and Aeronautics, University of Patras, Rion, 26504 Patra, Greece.
Bioengineering (Basel). 2021 Nov 20;8(11):189. doi: 10.3390/bioengineering8110189.
Cell biomechanics plays a major role as a promising biomarker for early cancer diagnosis and prognosis. In the present study, alterations in modulus of elasticity, cell membrane roughness, and migratory potential of MCF-7 (ER+) and SKBR-3 (HER2+) cancer cells were elucidated prior to and post treatment with conditioned medium from human umbilical mesenchymal stem cells (hUMSCs-CM) during static and dynamic cell culture. Moreover, the therapeutic potency of hUMSCs-CM on cancer cell's viability, migratory potential, and F-actin quantified intensity was addressed in 2D surfaces and 3D scaffolds. Interestingly, alterations in ER+ cancer cells showed a positive effect of treatment upon limiting cell viability, motility, and potential for migration. Moreover, increased post treatment cell stiffness indicated rigid cancer cells with confined cell movement and cytoskeletal alterations with restricted lamellipodia formation, which enhanced these results. On the contrary, the cell viability and the migratory potential were not confined post treatment with hUMSCs-CM on HER2+ cells, possibly due to their intrinsic aggressiveness. The increased post treatment cell viability and the decreased cell stiffness indicated an increased potency for cell movement. Hence, the therapy had no efficacy on HER2+ cells.
细胞生物力学作为一种有前景的生物标志物,在早期癌症诊断和预后评估中发挥着重要作用。在本研究中,在静态和动态细胞培养期间,用来自人脐带间充质干细胞的条件培养基(hUMSCs-CM)处理MCF-7(ER+)和SKBR-3(HER2+)癌细胞之前和之后,阐明了其弹性模量、细胞膜粗糙度和迁移潜力的变化。此外,在二维表面和三维支架中研究了hUMSCs-CM对癌细胞活力、迁移潜力和F-肌动蛋白定量强度的治疗效果。有趣的是,ER+癌细胞的变化表明治疗对限制细胞活力、运动性和迁移潜力具有积极作用。此外,处理后细胞硬度增加表明癌细胞刚性增强,细胞运动受限,细胞骨架改变,片状伪足形成受限,这进一步证实了这些结果。相反,用hUMSCs-CM处理HER2+细胞后,细胞活力和迁移潜力并未受到限制,这可能是由于它们固有的侵袭性。处理后细胞活力增加和细胞硬度降低表明细胞运动能力增强。因此,该疗法对HER2+细胞无效。